Evidence map›Paper›PMID 28261564›Full record

ArticleFrontiers in cellular and infection microbiology2017

Mary Speir, Adam Vogrin, Azadeh Seidi, Gilu Abraham, Stéphane Hunot, Qingqing Han, Gerald W Dorn, Seth L Masters, Richard A Flavell, James E Vince and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. BCL2L13: physiological and pathological meanings.Cellular and molecular life sciences : CMLS · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Mary SpeirDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University Clayton, VIC, Australia.
Adam VogrinDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University Clayton, VIC, Australia.
Azadeh SeidiDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University Clayton, VIC, Australia.
Gilu AbrahamDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University Clayton, VIC, Australia.
Stéphane HunotDepartment of Immunobiology, Howard Hughes Medical Institute, Yale University School of MedicineNew Haven, CT, USA; Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Institut du Cerveau et la Moelle - Hôpital Pitié-Salpêtrière, Boulevard de l'hôpital, Sorbonne Universités, UPMC Univ Paris 06Paris, France.
Qingqing HanDepartment of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine New Haven, CT, USA.
Gerald W DornDepartment of Medicine, Center for Pharmacogenomics, Washington University School of Medicine St. Louis, MO, USA.
Seth L MastersWalter and Eliza Hall Institute of Medical ResearchParkville, VIC, Australia; Department of Medical Biology, University of MelbourneParkville, VIC, Australia.
Richard A FlavellDepartment of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine New Haven, CT, USA.
James E VinceWalter and Eliza Hall Institute of Medical ResearchParkville, VIC, Australia; Department of Medical Biology, University of MelbourneParkville, VIC, Australia.
Thomas NadererDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University Clayton, VIC, Australia.
Monash University · AUYale University · USInstitut du Cerveau · FRUniversity of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AUWashington University in St. Louis · US

Funding

THE MITOCHONDRIAL DYNAMISM/FITNESS/BIOGENESIS INTERACTOME IN CARDIAC DISEASER35HL135736 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2017 to 2023
$6.4M
NHLBI NIH HHS R35 HL135736
6 · The paper itself

Abstract

The human pathogen

Indexed as

AnimalsApoptosisApoptosis Regulatory ProteinsBacterial ProteinsCell DeathCell SurvivalFemaleFlagellinGene DeletionHost-Pathogen InteractionsLegionella pneumophilaLegionnaires' DiseaseMacrophagesMembrane ProteinsMiceMitochondriaApoptosis Regulatory ProteinsBacterial ProteinsBNip3 protein, mouseFlagellinMembrane ProteinsMitochondrial ProteinsVirulence Factorsbacteriacaspasesinfectionlive-cell imagingmitochondriapneumoniapyroptosis

Identifiers

PMID28261564
PMCPMC5311068
OpenAlexW2588215328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.